|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项 # u+ m" K1 i. |
01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.
" p' p* k% l3 K% Y1 s02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor./ i6 ]5 M% T- M& W) u3 l3 B
03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.5 J2 e8 c4 q2 a# b( m
04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.9 m9 e" {6 r) F: Y
05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.; |5 w7 V9 a m+ b3 y4 V d0 f; ]' I
06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.
b6 z( T* u1 U5 z5 B+ o' @& q07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.) G! ]1 _1 E* E7 G8 q
08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.
2 Z9 _% s( i+ v4 f- }3 x; h+ |09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.) H" u8 m7 q' u& `% T5 j# Y2 K: j8 N& ~
10.Interpretable machine learning for prostate biopsy: Cohort study.8 w5 M) x [6 N* D, I
11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.
. U* V! X; H7 O1 S9 O8 Q12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.) }( n/ r3 @+ N, t2 g
13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).6 U- C/ B. r: e% W2 d
14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).3 D- V+ g* E, i3 l+ Q" z" k
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.
1 N: C" p% T, H6 h, P16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.
5 v9 s6 p, A# V; e @( A6 ]: Z. j17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors.% s3 u/ Z" T5 p' Q2 e% x
18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.
2 P0 r" e' x: n. _: N* f. B* L19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.
( b0 u$ Y, S- h! R: |3 I/ y20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.$ T' Z) V6 b* R, D( P0 A
21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.
# v4 x: v) n8 L22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.
! }" M7 p9 Z3 M6 O8 J- M, i23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.
4 D" J2 {$ u* a; h; U( K24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.
0 ?4 F! w, P. L% Y7 r5 Z, o25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.
) k7 Z1 q% g' J- M# h, \ |
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
